Cover Image
市場調查報告書

感冒、流感的OTC市場

OTC Cold & Flu

出版商 Nicholas Hall & Company 商品編碼 512739
出版日期 內容資訊 英文
訂單完成後即時交付
價格
Back to Top
感冒、流感的OTC市場 OTC Cold & Flu
出版日期: 2017年08月03日 內容資訊: 英文
簡介

本報告提供感冒、流感的OTC市場相關調查分析,主要OTC市場詳細相關的系統性資訊。

摘要整理

澳洲

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

巴西

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

加拿大

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

中國

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

哥倫比亞

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

法國

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

德國

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

印度

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

印尼

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

義大利

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

日本

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

墨西哥

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

波蘭

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

俄羅斯

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

韓國

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 免疫增強補充品
  • 預測

西班牙

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

泰國

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

英國

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

烏克蘭

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測

美國

  • 概要
  • 全身性的感冒、流感
  • 局部淤血消除藥
  • 胸部擦劑、吸入劑
  • 免疫增強補充品
  • 預測
  • 科學性研究

品牌的案例研究

  • Lemsip
  • Nasivin
  • Oscillococcinum
  • 0trivin
  • Sinupret
  • Sudafed
  • TheraFlu
  • Vicks
目錄

This report is an in-depth exploration of the OTC Cold & Flu market, including Systemic cold & flu, Topical decongestants and Chest rubs & inhalants, plus VMS brands positioned for immunity, and includes coverage of 20 major markets from across the globe, with topline sales, brand performances, new developments, launches and A+P campaigns.

With full-year 2016 OTC sales from DB6 2017, it also includes case studies of key OTC Cold & Flu brands, highlighting success factors, sales, NPD and A+P activity, with forecasts sales for all categories and countries, plus predictions for the future.

Key Features:

  • 20 national markets profiled in this report
  • An in-depth exploration of the Cold & Flu category, including Systemic cold & flu, Topical decongestants and Chest rubs & inhalants, plus supplements positioned for immunity
  • Forecast sales for all categories and countries, plus predictions for the future
  • Scientific studies investigated, and leading brands analysed in individual profiles

Key questions investigated in this report:

  • What have been the key drivers of growth in Cold & Flu in recent years, and what will be the key trends in future?
  • Which marketers and brands are outperforming the market and what can be learned from them?
  • Which regions and countries offer the most potent opportunities for future growth?
  • Will Switch and NPD benefit the Cold & Flu market in the years ahead, and what are the most promising new areas?

With global sales of $10.7bn in 2016, the combined categories of Systemic cold & flu, Topical decongestants and Chest rubs & inhalants grew by 5.6% on the previous year, significantly outpacing the global OTC market (+4.3%).

  • Europe enjoyed a strong year as key C&EE markets Russia, Poland and Ukraine rediscovered dynamism, while in W Europe the UK and Italy continued their impressive showing.
  • In Asia-Pacific, China, India and S Korea all improved on the previous year, Japan turned in its first positive performance in years, while Australia saw a downturn.
  • In North America, the huge US market slowed down, but Latin America posted double-digit growth boosted by Brazil, Mexico and Colombia.

The leading players in Cold & Flu† posted average growth of 3.3% in 2016, but this masks a diverse range of performances from players and their key brands. Discover how individual marketers and brands performed, both globally and in specific markets, and where the truly dynamic growth is coming from.

The report investigates immunity-boosting VMS brands, reviewing the OTC market for Immune supplements, Zinc supplements, Vitamin C, selected Multivitamins and Tonics & cure alls, among others. Have these preventive supplements impacted demand for self-care cold & flu treatments?

20 individual markets profiled in this report:

  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
  • North America
    • Canada
    • USA
  • Western Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
  • C&E Europe
    • Poland
    • Russia
    • Ukraine
  • Latin America
    • Colombia
    • Mexico
    • Brazil

Categories covered by this report:

Systemic cold & flu

  • Vitamin C
  • Zinc supplements

Topical decongestants

PLUS

  • Immune supplements
  • Other supplements for immunity

Chest rubs & inhalants

Table of Contents

Executive Summary

Australia

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

Brazil

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

Canada

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

China

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs &inhalants
  • Immunity-boosting supplements
  • Outlook

Colombia

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

France

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhala nts
  • Immunity-boosting supplements
  • Outlook

Germany

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

India

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs &inhalants
  • Immunity-boosting supplements
  • Outlook

Indonesia

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs &inhalants
  • Immunity-boosting supplements
  • Outlook

Italy

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

Japan

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

Mexico

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs &inhalants
  • Immunity-boosting supplements
  • Outlook

Poland

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs &inhalants
  • Immunity-boosting supplements
  • Outlook

Russia

  • Overview
  • Systemic cold & flu
  • LMI decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

S Korea

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Immunity-boosting supplements
  • Outlook

Spain

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

Thailand

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

UK

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook

Ukraine

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs &inhalants
  • Immunity-boosting supplements
  • Outlook

USA

  • Overview
  • Systemic cold & flu
  • Topical decongestants
  • Chest rubs & inhalants
  • Immunity-boosting supplements
  • Outlook
  • Scientific studies

Brand case studies

  • Lemsip
  • Nasivin
  • Oscillococcinum
  • 0trivin
  • Sinupret
  • Sudafed
  • TheraFlu
  • Vicks
Back to Top